Acella Pharmaceuticals, LLC
9005 Westside Parkway
Alpharetta
Georgia
30004
United States
Tel: 678-325-5189
Fax: 678-746-0717
Website: http://www.acellapharma.com/
22 articles about Acella Pharmaceuticals, LLC
-
A.forall Announces Launch of a Generic Version of Pyridostigmine Bromide Syrup
12/11/2023
Milla Pharmaceuticals Inc., an A.forall company, announced that its partner, Acella Pharmaceuticals LLC, has just commercialized its Abbreviated New Drug Application approval from the U.S. Food and Drug Administration for a generic version of Mestinon® 60 mg/5mL.
-
Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC Top MedReps Best Places to Work in Medical Sales
12/2/2021
Alora Pharmaceuticals today announced its subsidiaries Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC earned the top spot for small companies in MedReps Best Places to Work in Medical Sales 2022 survey, marking the fourth consecutive year of being honored.
-
Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency
4/29/2021
Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.
-
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
9/18/2020
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid ® , Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may have as low as 87% of the labeled amount
-
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
5/22/2020
Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid ® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk Stateme
-
Avion and Acella Pharmaceuticals Provide Statement Related to Avondale Drug Pricing News
12/14/2017
Avion and their partner company, Acella Pharma, recently responded to the recent news surrounding the Avondale Pharma product Niacor, a prescription version of niacin.
-
Acella Pharmaceuticals, LLC Signs Product Development Agreement With Catalent To Bring Opioid-Abuse Deterrents To Market
8/10/2017
-
Acella Pharmaceuticals, LLC, Announces Approval Of Generic To Vituz Oral Solution
7/27/2017
-
Acella Pharmaceuticals, LLC, Announces Approval Of A Generic Bromfed Antihistamine/Decongestant
10/28/2016
-
Acella Pharmaceuticals, LLC, Announces Appointment Of New Chief Executive Officer
4/8/2016
-
Acella Pharmaceuticals, LLC Announces Approval Of Tranexamic Acid Injection
6/10/2014
-
Acella Pharmaceuticals, LLC Announces Approval And Launch Of Loutrex Topical Cream
1/31/2014
-
Everett Laboratories Files Patent Infringement Lawsuits Against Competitor Acella Pharmaceuticals, LLC
7/8/2013
-
Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
7/10/2012
-
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
5/2/2012
-
Acella Pharmaceuticals, LLC Announces a New Addition to the Commercial Team
5/1/2012
-
Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the FDA
2/21/2012
-
Acella Pharmaceuticals, LLC Names Allen Fields as New VP, Head of R&D
2/15/2012
-
Acella Pharmaceuticals, LLC Names Allen Fields as New VP, Head of R&D
2/15/2012
-
Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE(R) Family of Trademarks and Associated Intellectual Property, Will Hire 80 Sales Associates to Promote Brand
1/6/2012